9(15): 575667 Flatters SJ, Bennett GJ
doi: 10.1039/D0FO00524J
Respecting the clinical trial and FDA process matters especially for people with severe obesity, who deserve treatments proven to be not only effective, but safe, reliable, and appropriately monitorednot risky counterfeit shortcuts fueled by hype
PlexusDx has no affiliate arrangement, partnership, or paid relationship with Noom or its parent company
(Health Canada greenlit the use of semaglutide for weight loss in 2021 but massive global demand delayed it being rolled out.) According to the pricing structure of the pan-Canadian Pharmaceutical Alliance, when two generic medications enter the market, they are at least 50 per cent cheaper than the brand name but companies can price them lower
There is, however, a plausible reason to investigate the connection